Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters  

作　　者：Ya-Nan Zhang Zhe-Rui Zhang Hong-Qing Zhang Na Li Qiu-Yan Zhang Xiao-Dan Li Cheng-Lin Deng Fei Deng Shuo Shen Bing Zhu Bo Zhang 

机构地区：[1]Virus Laboratory,Institute of Pediatrics,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China [2]Key Laboratory of Special Pathogens and Biosafety,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China [3]University of Chinese Academy of Sciences,Beijing 100049,China [4]Hunan Normal University,School of Medicine,Changsha 410081,China [5]Wuhan Institute of Biological Products Co.Ltd,Wuhan 420115,China

出　　处：《Signal Transduction and Targeted Therapy》2022年第3期632-634,共3页信号转导与靶向治疗（英文）

基　　金：We thank the National Key Research and Development Program of China(2018YFA0507201)for grant support.We thank the National Virus Resource center for making Omicron available.

摘　　要：Dear Editor,The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)continues to disrupt global public health since its first report in December 2019,resulting in more than 380 billion confirmed cases including nearly 5.7 billion deaths worldwide(https://covidl9.who.int).

关 键 词：ACUTE PATHOGENESIS RESPIRATORY 

分 类 号：R563.1[医药卫生—呼吸系统]